TELA Bio, Inc.
TELA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $86,150 | $151,391 | $187,078 | $185,257 |
| - Cash | $52,670 | $46,729 | $42,019 | $43,931 |
| + Debt | $41,669 | $41,080 | $40,256 | $31,491 |
| Enterprise Value | $75,149 | $145,742 | $185,315 | $172,817 |
| Revenue | $69,300 | $58,453 | $41,418 | $29,463 |
| % Growth | 18.6% | 41.1% | 40.6% | – |
| Gross Profit | $46,488 | $40,112 | $27,044 | $18,813 |
| % Margin | 67.1% | 68.6% | 65.3% | 63.9% |
| EBITDA | -$31,683 | -$40,633 | -$39,058 | -$29,144 |
| % Margin | -45.7% | -69.5% | -94.3% | -98.9% |
| Net Income | -$37,841 | -$46,664 | -$44,296 | -$33,276 |
| % Margin | -54.6% | -79.8% | -106.9% | -112.9% |
| EPS Diluted | -1.33 | -2.04 | -2.73 | -2.3 |
| % Growth | 34.8% | 25.3% | -18.7% | – |
| Operating Cash Flow | -$41,595 | -$40,857 | -$40,748 | -$30,432 |
| Capital Expenditures | -$989 | -$611 | -$1,872 | -$627 |
| Free Cash Flow | -$42,584 | -$41,468 | -$42,620 | -$31,059 |